Health NZ | Te Whatu Ora FHIR Screening Implementation Guide
0.9.2 - draft New Zealand flag

Health NZ | Te Whatu Ora FHIR Screening Implementation Guide - Local Development build (v0.9.2) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

National Cervical Screening Programme

Screening History Report

As at 06-03-2024

Participant Details

       
Full Name Madeleine Meringue Date of Birth 24-11-2008
Ethnicity New Zealand European NHI Number ZCU7824
Gender Female Sex assigned
at birth
Female
Address 373 Jackson Street, Petone,
Lower Hutt 5012, New Zealand
   

Participant Summary

       
Pathway Status 5 Year Recall Immune Deficient No
Next Expected Event Eligibility Notification Total Hysterectomy No
Next Event Due Date 24-11-2033 Cervical Cancer No
Send programme
correspondence
Yes    
Unenrolled reason Patient overseas for 2 years    

Screening History

Cytology Test, specimen taken 27-01-2024

   
Specimen Type LBC - Liquid based cytology
Specimen Id ZKJ2269
Site Code R- Cervical
Specimen Taker Mickey Dee
Requested By Facility Dr Jane John Surgery
Received By Facility Allana Family Planning Clinic
Adequacy S1 - The specimen is satisfactory for evaluation
Interpretation 02 - There are fungal organisms morphologically consistent with Candida species
General Category G1 - CYTOLOGY: NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNACY
Recommendation H1 - Please recall in three years for HPV primary screening test, or in 12 months if the screening participant is immune deficient
Grade N- Negative

Cytology Test, specimen taken 27-01-2021

   
Specimen Type LBC - Liquid based cytology
Specimen Id ZKJ2269
Site Code R- Cervical
Specimen Taker Mickey Dee
Requested By Facility Dr Jane John Surgery
Received By Facility Allana Family Planning Clinic
Adequacy S1 - The specimen is satisfactory for evaluation
Interpretation 02 - There are fungal organisms morphologically consistent with Candida species
General Category G1 - CYTOLOGY: NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNACY
Recommendation H1 - Please recall in three years for HPV primary screening test, or in 12 months if the screening participant is immune deficient
Grade N- Negative